Article Text
Statistics from Altmetric.com
Adevastating complication arising early in the treatment of the relatively common condition of giant cell arteritis altered my management of subsequent cases even though guidance from clinical trials was not available, a problem for the management of a number of other well known diseases.
CASE 1
A woman in her fifties was referred urgently from the ophthalmology emergency department to the rapid access neurology outpatient clinic. She gave a 24 hour history of sudden loss of vision in her partially amblyopic left eye on a background of being mildly hypertensive, moderately overweight, with marginally raised serum cholesterol. She was on an ACE inhibitor but no aspirin and no “statin”. She had not smoked for two decades. She also gave a six week history of tiredness, minor malaise, and minimal myalgia. She was not prone to headaches but had had bi-temporal headache which was not severe, intermittently for two weeks. She had not noticed any scalp tenderness. There was no jaw claudication.
Visual acuity on the left had fallen from 6/18 at a recent optician’s examination to detecting hand movements. The optic nerve head was pale and swollen with a few splinter shaped haemorrhages. On the right side, acuity was 6/6 with a normal looking nerve head. The superficial temporal arteries were prominent and only slightly tender. There was no muscle tenderness. Blood pressure was 145/85.
Investigations revealed an ESR of 28 and a C-reactive protein (CRP) of 30. Full blood count …
Read the full text or download the PDF:
Other content recommended for you
- An elastic Van Gieson stain is unnecessary for the histological diagnosis of giant cell temporal arteritis
- Temporal artery biopsy in the management of giant cell arteritis with neuro-ophthalmic complications
- Giant cell arteritis
- 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
- Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care
- Visual loss in giant cell arteritis 3 weeks after steroid initiation
- Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips
- Extensive intracranial involvement with multiple dissections in a case of giant cell arteritis
- Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases
- New headaches with normal inflammatory markers: an early atypical presentation of giant cell arteritis